ArticleInternational journal of molecular sciences2022

Experimental and Clinical Evidence Suggests That Treatment with Betacellulin Can Alleviate Th2-Type Cytokine-Mediated Impairment of Skin Barrier Function.

Ge Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.